Injective falls 7.30% as sharp reversal erases prior gains

Traders Union
All News
Crypto News
Injective drops 7.3% today to $4.81

Highlights

INJ remains in a sustained uptrend, trading well above short-, medium-, and long-term moving averages.
Despite strong momentum signals, multiple overbought indicators and a sharp 7% intraday decline suggest elevated risk of a short-term pullback.
Price is expected to consolidate between $4.60 and $5.25 over the next five days, with downside risk favored while overbought conditions reset.

Bullish momentum at odds with overbought risk and intraday reversal

On the technical front, INJ's price is currently above the daily SMA-20 ($4.01), SMA-50 ($3.42), and SMA-200 ($4.42). The Ichimoku Kijun level at $4.64 serves as immediate support. Momentum indicators show a mixed picture: the MACD and ADX on the daily chart reflect strong bullish momentum, while the RSI (84.31), Stoch RSI (100), and CCI (175.35) are all in overbought territory, flagging heightened risk of a near-term pause or reversal. Bull/Bear Power (BBP) also signals an overbought environment. Despite prevailing daily momentum, today's session was marked by a 7.3% drop, a close near the session low, and a lack of significant gap from the previous close, all pointing to profit-taking and intensified intraday volatility. The Awesome Oscillator (AO) continues to support the broad uptrend, but the sharp intraday reversal introduces a notable divergence between daily momentum and short-term price behavior.

Consolidation expected as downside risk overshadows upside breakout

In the short term, the typical volatility band for INJ over the next five trading days is expected between $4.60 and $5.25. The probability of further price gains is low (below 20%), while short-term downside risk is elevated. Baseline expectations are for INJ to consolidate sideways within this corridor. A bullish scenario would require a breakout above $5.25 with renewed buying strength, while a close below $4.60 could trigger a deeper pullback as overbought readings unwind.

Viktoras Karapetjanc, expert at Traders Union, sees INJ holding its broader uptrend above key technical supports, despite a sharp daily decline. He notes robust bullish momentum and recognizes overbought signals may lead to sideways trading in the near term. The analyst highlights that, absent any significant news flow, the focus shifts to technical signals and the probability of consolidation. Short-term risks remain, but Karapetjanc is optimistic about the underlying trend. "Even after this volatile shakeout, I believe momentum can reassert if INJ holds above $4.60 — I remain constructive on the medium-term outlook."

Earlier, analysts noted that Injective maintained a bullish technical structure but faced heightened overbought pressures and elevated short-term downside risk. With the current session amplifying signs of profit-taking and volatility, traders should now watch the $4.60 support as pivotal for signaling whether a deeper corrective phase or renewed consolidation will prevail.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.